Riskpilot← Back to searchSign inGet full accessAgntho's AB
ABActiveOrg 5565345344Agavägen 52 AWholesale of pharmaceutical and medical goods · NACE 4646Est. 19965-9 employees
Revenue 2025
SEK 14,6M
+2% vs 2024
EBITDA margin
6.6%
+73% vs 2024
Equity ratio
67.3%
Financial strength
Net profit 2025
SEK 1,1M
+23% vs 2024
| Revenue | SEK 14,6M | +2% |
| EBITDA | SEK 959K | +73% |
| Net profit | SEK 1,1M | +23% |
| Total assets | SEK 7,7M | +0% |
| Equity | SEK 5,2M | +4% |
| Employees | — | — |
Legal name
Agntho's AB
Org number
5565345344
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3 oktober 1996
Share capital
SEK 100 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva handels- och agenturrörelse huvudsakligen med medicinska instrument och livsmedel, bedriva konsultverksamhet inom dessa områden och därmed förenlig verksamhet samt äga och förvalta lös och fast egendom.
Address
Agavägen 52 A
Phone
+4687665715
Email
agnthos@agnthos.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 13 636 | 12 488 | 15 339 | 14 369 | 14 585 |
| Staff expenses | — | −2 790 | −3 013 | −3 406 | −3 549 |
| EBITDA | 1 290 | 1 284 | 1 406 | 555 | 959 |
| Depreciation & amort. | −23 | −18 | −3 | −20 | −1 |
| EBIT | 1 267 | 1 266 | 1 403 | 536 | 958 |
| Net financials | −4 | 10 | 101 | 93 | 43 |
| Profit before tax | 1 252 | 1 587 | 2 001 | 1 168 | 1 402 |
| Tax | −295 | −375 | −457 | −284 | −312 |
| Net profit | 957 | 1 212 | 1 544 | 883 | 1 090 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7 894 | 8 302 | 9 290 | 7 718 | 7 746 |
| Equity | 4 004 | 4 556 | 5 040 | 5 023 | 5 213 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 1 532 | 1 531 | 2 365 | 1 180 | 1 319 |
| Total debt | 1 532 | 1 531 | 2 365 | 1 180 | 1 319 |
EBITDA margin
6.6%
This company
15.8%
Market median
-58% vs market
20212025
Equity ratio
67.3%
This company
38.2%
Market median
+76% vs market
20212025
Return on equity
20.9%
This company
18.4%
Market median
+14% vs market
20212025
Net profit margin
7.5%
This company
8.1%
Market median
-7% vs market
20212025
Asset turnover
1.88×
This company
1.12×
Market median
+68% vs market
20212025
Debt / equity
0.49×
This company
0.62×
Market median
+21% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AB Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Agntho's AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Birgitta Christina Nordberg | Chief Auditor | 0 companies |
| Per Johan Emil Eliasson | Chairman | 0 companies |
| Viva Agneta Fahlgren | Deputy Board Member | 0 companies |
| Carl Johan Fredrik Ring | Board of Directors | 0 companies |